Small Cell Lung Cancer Enters The Era Of Precision Medicine

In this issue of Cancer Cell, Gay et al. describe a molecular classification of small cell lung cancers and extend prior studies that highlight the potential for personalized treatments. Notably, they identify a new ``inflamed'' subtype that may emerge following acquired chemoresistance but which may become more susceptible to immunotherapy.